Brookline Capital Markets has expanded its healthcare investment banking services team with five new hires. Joining the company are Dr. Kumar Raja as senior biotechnology analyst; Graham A. Powis as senior capital markets adviser; Dr. Samuel P. Wertheimer as senior scientific adviser; Michael D. Rhea as managing director of institutional sales; and Joseph A. LaSala as senior associate of investment banking. NEW YORK–(BUSINESS WIRE)–Brookline Capital Markets (“Brookline”) is pleased to announce the recent expansion of its healthcare investment banking services and team.